NASDAQ · POCI

Precision Optics Corporation, Inc.

$4.30 $0.00 (+0.00%) 1D Market open

Key Metrics

$47.06M
Market cap
55.27×
P/E · TTM
$9.85M
Revenue · TTM
$851.59K
Net income
EPS · TTM $0.11
Dividend yield
Free cash flow
Beta · 1Y 0.33
EBITDA · TTM
Gross margin 6.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 5
    The stock moved +8.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 5
  • Apr 7
    From its Feb 5 high, the share price fell 34%.

    Peak close $5.94 on Feb 5; trough close $3.90 on Apr 7. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%
  • Feb 4
    The stock moved +11.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 4

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$47.06M
Enterprise value$37.82M
Shares outstanding10.9M
52-wk range$3.55 – $6.15
Avg volume · 20D15.9K
Net cash $9.25M
Book value / share$2.60
IndustryElectromedical & Electrotherapeutic Apparatus
ExchangeNASDAQ
About Precision Optics Corporation, Inc.
IPO dateJan 16, 1992
Employees90

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E55.27
P/S4.78
P/FCF
EV/EBITDA
EV/Sales3.84
Graham №$2.54

Profitability

Gross 6.1%
Operating 7.7%
Net 8.6%
FCF
ROE / ROIC 5.6% · —

Financial Health

Current ratio2.10
Quick ratio1.74
Debt / equity0.07
Debt / EBITDA
Net cash $9.25M
Working capital$11.21M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

0.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$2.54 vs $4.30
Trades 1.7× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings